Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7R59

PARP2 catalytic domain in complex with OUL245

Summary for 7R59
Entry DOI10.2210/pdb7r59/pdb
DescriptorPoly [ADP-ribose] polymerase 2, GLYCEROL, [1,2,4]triazolo[3,4-b][1,3]benzothiazol-6-ol, ... (4 entities in total)
Functional Keywordsinhibitor, complex, parp, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight40180.21
Authors
Galera-Prat, A.,Maksimainen, M.M.,Lehtio, L. (deposition date: 2022-02-10, release date: 2023-01-25, Last modification date: 2024-02-07)
Primary citationMurthy, S.,Nizi, M.G.,Maksimainen, M.M.,Massari, S.,Alaviuhkola, J.,Lippok, B.E.,Vagaggini, C.,Sowa, S.T.,Galera-Prat, A.,Ashok, Y.,Venkannagari, H.,Prunskaite-Hyyrylainen, R.,Dreassi, E.,Luscher, B.,Korn, P.,Tabarrini, O.,Lehtio, L.
[1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes.
J.Med.Chem., 66:1301-1320, 2023
Cited by
PubMed Abstract: We report [1,2,4]triazolo[3,4-]benzothiazole (TBT) as a new inhibitor scaffold, which competes with nicotinamide in the binding pocket of human poly- and mono-ADP-ribosylating enzymes. The binding mode was studied through analogues and cocrystal structures with TNKS2, PARP2, PARP14, and PARP15. Based on the substitution pattern, we were able to identify 3-amino derivatives (OUL243) and (OUL232) as inhibitors of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15 at nM potencies, with being the most potent PARP10 inhibitor described to date (IC of 7.8 nM) and the first PARP12 inhibitor ever reported. On the contrary, hydroxy derivative (OUL245) inhibits poly-ARTs with a selectivity toward PARP2. The scaffold does not possess inherent cell toxicity, and the inhibitors can enter cells and engage with the target protein. This, together with favorable ADME properties, demonstrates the potential of TBT scaffold for future drug development efforts toward selective inhibitors against specific enzymes.
PubMed: 36598465
DOI: 10.1021/acs.jmedchem.2c01460
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon